Recent acquisitions have made BASF the world's largest supplier of high-concentration omega-3 ingredients.
With recent acquisitions of omega-3 suppliers Cognis, Equateq Ltd., and Pronova BioPharma, BASF (Ludwigshafen, Germany) is calling itself a “verbund powerhouse” of omega-3 ingredients. At the SupplySide West trade show in Las Vegas this year, the company introduced itself for the first time as the world’s largest supplier of high-concentration omega-3s.
The newly improved BASF says its collection of omega-3 ingredients now includes natural fish oils, standard-grade concentrates, and high to super-high concentrates. While standard-grade fish oils typically house around 30–40% omega-3 EPA and DHA, BASF spokesperson Caron Blitz says higher grades can yield as much as 60% omega-3 EPA and DHA in smaller pills.
“Our customers are looking for choices, and this gives them more choices,” says Blitz. “They can keep fish oil and make it easy to swallow, or they can blend in other ingredients based on health conditions or target audiences.”
BASF’s recent acquisitions also give the company new bottling and labeling services.
GC Rieber VivoMega uses AI platform from Intelecy to boost efficiency, quality, and sustainability
August 26th 2024According to the company’s announcement, the AI platform is able to identify real-time deviations or anomalies in GC Rieber VivoMega’s processing facilities and report them via a cloud-based, comprehensive, centralized system.
SourceOne Global Partners to distribute Qualitas Health’s microalgae omega-3 ingredient globally
August 15th 2024SourceOne Global Partners has announced a partnership with Qualitas Health Inc., (dba iwi life) to introduce the company’s trademarked AlmegaPL microalgae omega-3 ingredient to the global marketplace.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.